Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 7/20 | 0.39 |
| ▸ | PAM | P19021 | 2/20 | 0.38 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31542572 | 0.93 | TDP1 (0.41) | DGKATDP1ELANEPAMP2RX7 | |
| SCHEMBL30886860 | 0.93 | DGKA (0.36) | DGKATDP1ELANEPAMMAPT | |
| SCHEMBL668958 | 0.93 | DGKA (0.36) | DGKATDP1ELANEPAMMAPT | |
| SCHEMBL20581979 | 0.90 | TDP1 (0.38) | TDP1TSHRMAPTALDH1A1 | |
| SCHEMBL483438 | 0.85 | DGKA (0.43) | DGKATDP1ELANEPAMP2RX7 | |
| SCHEMBL2905259 | 0.85 | DGKA (0.43) | DGKATDP1ELANEPAMP2RX7 | |
| SCHEMBL4971394 | 0.82 | KDM4E (0.43) | DGKAMAPTALDH1A1LMNA | |
| SCHEMBL5153439 | 0.82 | MAPT (0.39) | MAPTALDH1A1 | |
| SCHEMBL9232006 | 0.81 | KDM4E (0.51) | DGKAELANEPAMALDH1A1LMNA | |
| SCHEMBL516267 | 0.81 | KDM4E (0.51) | DGKAELANEPAMALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12396934-B2 | Powder cosmetic | JO COSMETICS CO., LTD. (JP) | 2025-08-26 | — | — | US | disclosed |
| US-12383476-B2 | W/O/W emulsion composition | SHISEIDO COMPANY, LTD. (JP) | 2025-08-12 | — | — | US | disclosed |
| CN-120131453-A | W/O/W type emulsified composition | 株式会社资生堂 | 2025-06-13 | — | — | CN | disclosed |
| WO-2025070287-A1 | HAIR COSMETIC | 日油株式会社 | 2025-04-03 | — | — | WO | disclosed |
| US-12151010-B2 | Skin lightening agent | POLA CHEMICAL INDUSTRIES, INC. (JP) | 2024-11-26 | — | — | US | disclosed |
| US-12029303-B2 | Method for preparation of a cosmetic kit | SHISEIDO COMPANY, LTD. (JP) | 2024-07-09 | — | — | US | disclosed |
| WO-2024142969-A1 | WATER-IN-OIL EMULSION COMPOSITION | 株式会社 資生堂 | 2024-07-04 | — | — | WO | disclosed |
| WO-2024142846-A1 | COSMETIC COMPOSITION | 株式会社 資生堂 | 2024-07-04 | — | — | WO | disclosed |
| WO-2024142892-A1 | W/O/W EMULSIFIED COMPOSITION | 株式会社 資生堂 | 2024-07-04 | — | — | WO | disclosed |
| WO-2024142843-A1 | COSMETIC COMPOSITION | 株式会社 資生堂 | 2024-07-04 | — | — | WO | disclosed |
| EP-1292266-B1 | PYRIDOXINE AS NOVEL COUPLING COMPONENT FOR OXIDATIVE HAIR DYES | HENKEL KGAA (DE) | 2005-11-16 | — | — | EP | disclosed |
| EP-1292263-B1 | VITAMIN B6 DERIVATIVES AS PROTECTIVE COMPONENTS IN THE OXIDATIVE TREATMENT OF HAIR | HENKEL KGAA (DE) | 2005-11-02 | — | — | EP | disclosed |
| EP-1292265-A1 | STRUCTURE-IMPROVING HAIR CARE AGENTS | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-03-19 | — | — | EP | disclosed |
| EP-1292264-A2 | AGENT FOR DYEING OR COLORING AND SIMULTANEOUSLY PROTECTING HAIR | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-03-19 | — | — | EP | disclosed |
| EP-1292266-A2 | NOVEL COUPLING COMPONENT FOR OXIDATIVE HAIR DYES | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-03-19 | — | — | EP | disclosed |
| EP-1292263-A2 | VITAMIN B6 DERIVATIVES AS PROTECTIVE COMPONENTS IN THE OXIDATIVE TREATMENT OF HAIR | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-03-19 | — | — | EP | disclosed |
| WO-2001097756-A2 | NOVEL COUPLING COMPONENT FOR OXIDATIVE HAIR DYES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-12-27 | — | — | WO | disclosed |
| WO-2001097760-A1 | STRUCTURE-IMPROVING HAIR CARE AGENTS CONTAINING VITAMIN B6 AND DERIVATIVES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-12-27 | — | — | WO | disclosed |
| WO-2001097755-A2 | VITAMIN B6 DERIVATIVES AS PROTECTIVE COMPONENTS IN THE OXIDATIVE TREATMENT OF HAIR | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-12-27 | — | — | WO | disclosed |
| WO-2001097757-A2 | AGENT FOR DYEING OR COLORING AND SIMULTANEOUSLY PROTECTING HAIR | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2001-12-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12151010-B2 | Skin lightening agent | ACOX1, HAO1, CBR1 | DGKA 4026/4885TDP1 4244/4885ELANE 905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.